These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 237402)

  • 1. Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol.
    Regårdh CG
    Acta Pharmacol Toxicol (Copenh); 1975; 37(1):1-39. PubMed ID: 237402
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Relationship between the pharmacokinetic and pharmacodynamic properties of the beta-receptor antagonists alprenolol and metoprolol.
    Regardh CG; Ablad B; Borg KO; Johnsson G; Solvell L
    Acta Pharm Suec; 1974 Dec; 11(6):660. PubMed ID: 237405
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative bioavailability and effect studies on metoprolol administered as ordinary and slow-release tablets in single and multiple doses.
    Regårdh CG; Johnsson G; Jordö L; Sölvell L
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 5):45-58. PubMed ID: 1079687
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined pharmacokinetic and pharmacodynammc studies in man of the adrenergic beta1-receptor antagonist metoprolol.
    Johnsson G; Regårdh CG; Sölvell L
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 5):31-44. PubMed ID: 1094802
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetic studies of metoprolol-(3-h) in the rat and the dog.
    Borg KO; Fellenius E; Johansson R; Wallborg M
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 5):104-15. PubMed ID: 1079683
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical pharmacology of trimepranol (pharmacokinetic informations and effects on heart rate in healthy individuals)].
    Mayer O; Petrlík M; Vitous J; Cepelák V
    Vnitr Lek; 1976 Nov; 22(11):1102-9. PubMed ID: 12612
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.
    Shand DG
    Drugs; 1974; 7(1):39-47. PubMed ID: 4151694
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined pharmacokinetic and pharmacodynamic studies of metoprolol in the cat and the dog.
    Borg KO; Carlsson E; Ek L; Johansson R
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 5):24-30. PubMed ID: 1094801
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biotransformation and pharmacokinetics of beta-receptor blockaders].
    Pfeifer S; Zimmer C
    Pharmazie; 1975 Oct; 30(10):625-33. PubMed ID: 685
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma levels and effects of metoprolol on blood pressure and heart rate in hypertensive patients after an acute dose and between two doses during long-term treatment.
    Bengtsson C; Johnsson G; Regårdh CG
    Clin Pharmacol Ther; 1975 Apr; 17(4):400-8. PubMed ID: 235398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the metabolism of the beta-adrenoceptor antagonists alprenolol, metoprolol and pamatolol.
    Hoffmann K
    Acta Pharm Suec; 1979; 16(2):160. PubMed ID: 38629
    [No Abstract]   [Full Text] [Related]  

  • 12. Contribution of 4-hydroxy-alprenolol to adrenergic beta receptor blockade of alprenolol.
    Collste P; Borg KO; Aström H; von Bahr C
    Clin Pharmacol Ther; 1979 Apr; 25(4):416-22. PubMed ID: 34497
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative hemodynamic studies in man of adrenergic bepta-1-receptors agents without (h 93/26 equal to metoprolol) or with (h 87/07) intrinsic sympathicomimetic activity.
    Stenberg J; Wasir H; Amery A; Sannerstedt R; Werkö L
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 5):76-84. PubMed ID: 237401
    [No Abstract]   [Full Text] [Related]  

  • 14. The pharmacokinetics of dl- and l-moprolol in the human.
    Harvengt C; Desager JP
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):57-61. PubMed ID: 6120901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administration.
    Bianchetti G; Blatrix C; Gomeni R; Kilborn JR; Larribaud J; Lücker PW; Thebault JJ; Trocherie S; Morselli PL
    Arzneimittelforschung; 1980; 30(11):1912-6. PubMed ID: 6109538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic studies on the selective beta1-receptor antagonist metoprolol in man.
    Regårdh CG; Borg KO; Johansson R; Johnsson G; Palmer L
    J Pharmacokinet Biopharm; 1974 Aug; 2(4):347-64. PubMed ID: 4155762
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of SD/1601 on tolerance to exercise in patients with angina.
    Maggi A; Mariani G; Tettamanti R; Tallone G
    G Ital Cardiol; 1975; 5(1):142-8. PubMed ID: 235477
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
    Horii D; Kawada T; Takeda K; Imai S
    Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetic parameters of bevantolol in volunteers.
    Vermeij P; van Brummelen P
    Eur J Clin Pharmacol; 1986; 30(3):375-7. PubMed ID: 2874033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of the pharmacological properties of metoprolol in animals and man.
    Ablad B; Borg KO; Carlsson E; EK L; Johnson G; Malmfors T; Regårdh CG
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 5):7-23. PubMed ID: 1094804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.